Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 7, 2009, Pages 1107-1112

  Amado, I ^a   Bourdel, M C ^a   Daban, C ^a   Poirier, M F ^a   Loo, H ^a   Bouhours, P ^b   Krebs, M O ^a  

^a INSERM   (France)

^b Medical Department   (France)

Author keywords

Disorganization; Gap; Risperidone; Schizophrenia; Visual orienting

Indexed keywords

BIPERIDEN; HYDROXYZINE; RISPERIDONE;

ADULT; ALERTNESS; ANXIETY DISORDER; ARTICLE; ASSOCIATION; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISORIENTATION; DRUG DOSE TITRATION; EDUCATIONAL STATUS; EXTRAPYRAMIDAL SYMPTOM; EYE FIXATION; EYE MOVEMENT DISORDER; FEMALE; HUMAN; INSOMNIA; INTELLIGENCE QUOTIENT; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; REACTION TIME; SCHIZOPHRENIA; SCORING SYSTEM; STIMULUS RESPONSE; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL DISCRIMINATION; VISUAL ORIENTATION; VISUAL STIMULATION;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHOICE BEHAVIOR; CUES; EYE MOVEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIA, DISORGANIZED; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 69549084566     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.06.004     Document Type: Article

References (37)

1. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorder. 4th edition (2000), TR, APA, Washington DC
2. Braff D.L., and Light G.A. Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology 174 (2004) 75-85
3. Britton P.G., and Savage R.D. A short form of the WAIS for use with age. Br J Psychiatry 112 (1966) 417-418
4. Carter C.S., Robertson L.C., Chaderjian M.R., Celaya L.J., and Nordahl T.E. Attentional asymmetry in schizophrenia: controlled and automatic processes. Biol Psychiatry 31 (1992) 909-918
5. Cleghorn J.M., Kaplan R.D., Szechtman B., Szechtman H., and Brown G.M. Neuroleptic drug effects on cognitive function in schizophrenia. Schizophr Res 3 3 (1990) 211-219
6. Daban C., Amado I., Gut A., Leonardi S., Willard D., Bourdel M.C., et al. Disorganisation syndrome is correlated to working memory deficits in unmedicated patients with recent onset schizophrenia. Schizophr Res 61/2-3 (2003) 323-324
7. Daban C., Krebs M.O., Bourdel M.C., Willard D., Lôo H., Olié J.P., et al. Effects of atypical neuroleptics on alertness and visual orienting in stabilised schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol 7 (2004) 255-263
8. Danckert J., Saoud M., and Maruff P. Attention, motor control and motor imagery in schizophrenia: implications for the role of the parietal cortex. Schizophr Res 70 2-3 (2004) 241-261
9. Fisher B., and Breitmeyer B. Mechanisms of visual attention revealed by saccadic eye-movements. Neuropsychologia 25 (1987) 73-83
10. Gomez C., Millan S., Atienza M., Aguilar-Bravo H., Vazquez, and Delinte A. The gap effect during visual and auditory stimulation using manual responses. Biol Psychol 47 (1998) 77-96
11. Harvey P., Rabinowitz J., Eerdekens M., and Davidson M. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long term trial. Am J Psychiatry 162 10 (2005) 1888-1895
12. Hill S.K., Schuebpach D., Herbener E.S., Keshavan M.S., and Sweeney J.A. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophr Res 68 (2004) 49-63
13. Hillyard S.A., and Picton T.W. Electrophysiology of cognition. In: Plum F. (Ed). Handbook of physiology: higher functions of the nervous system. Section &: the nervous system. Higher function of the brain. Part 2 vol. V (1987), American Physiological Society, Bethesda. MD 519-583
14. Hong K.S., Kim J.G., Koh M.H., Kim H.G., and Kim E. Effects of risperidone on information processing and attention in first-episode schizophrenia. Schizophr Res 53 (2002) 7-16
15. Kay S.R., and Opler L.A. Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
16. Kingstone A., and Klein R.M. What are human express saccades?. Percept Psychophys 54 (1993) 260-273
17. Klein R.M. Inhibition of return. Trends Cogn Sci 4 (2000) 138-145
18. Lançon C., Afghababian V., Llorca P.M., Bernard D., and Auguier P. An exploration of the psychometric properties of the French version of the Positive and Negative syndrome Scale. Can J Psychiatry 44 9 (1999) 893-900
19. Lépine J.P., Piron J.J., and Chapotot E. Factor analysis of the PANSS in schizophrenic patients. Proceeding of the 8th International Congress of Psychiatry. Psychiatry today: accomplishments and promises, Abstr 3232 (1989), Excerpa Medica, Amsterdam 1 Oct 12-19; Athens, Greece
20. Lussier I., and Stip E. Memory and attention deficits in drug naïve patients with schizophrenia. Schizophr Res 48 (2001) 45-55
21. Maruff P., Hay D., Malone V., and Currie J. Asymmetries in the covert orienting of visual spatial attention in schizophrenia. Neuropsychologia 33 (1995) 1205-1223
22. Matsue Y., Osakabe K., Saitu H., Goto Y., Ueno T., Matsuoka H., et al. Smooth pursuit eye movements and express saccades in schizophrenic patients. Schizophr Res 12 (1994) 121-130
23. Meltzer H.Y., and McGurk S. The effects of clozapine, ripseridone and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25 (1999) 233-255
24. Nestor P.G., Faux S.F., and McCarley R.W. Attentional cues in chronic schizophrenia: abnormal disengagement of attention. J Abnorm Psychol 101 (1992) 682-689
25. Ngan E.T.C., and Liddle P.F. Reaction time, symptom profile and course of illness in schizophrenia. Schizophr Res 46 2-3 (2000) 195-201
26. Nuechterlein K.H., Edell W.S., Norris M., and Dawson M.E. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull 12 3 (1986) 408-426
27. Nurnberger J.I., Blehar M.C., and Kaufmann C.A. Diagnostic interview for Genetic Studies: rational, unique features and training. Arch Gen Psychiatry 51 (1994) 849-859
28. Pandurangi A.K., Sax K.W., Pelonero A.L., and Goldberg S.C. Sustained attention and positive formal thought disorder in schizophrenia. Schizoph Res 13 2 (1994) 109-116
29. Posner M.I. Orienting of attention. Q J Exp Psychol 32 1 (1980) 3-25
30. Posner M.I., Rafal R.D., Choate L.S., et al. Inhibition of return: neural basis and function. Cogn Neuropsychol 2 (1985) 211-228
31. Posner M.I., Early T.S., and Reiman E. Asymmetries in hemispheric control of attention in schizophrenia. Arch Gen Psychiatry 45 (1988) 814-821
32. Reilly J., Harris M., Keshavan M., and Sweeney J.A. Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia. Biol Psychiatry 57 (2005) 145-154
33. Reilly J.L., Harris M.S., Khine T.T., Keshavan M.S., and Sweeney J.A. Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia. Biol Psychiatry 63 8 (2008) 776-783
34. Stip E., and Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry 41 S2 (1996) 35-40
35. Strauss M.E., Novakovic T., Tien A.Y., Bylsma F., and Pearlson G.D. Disengagement of attention in schizophrenia. Psychiatry Res 37 (1991) 139-146
36. Wigal S.B., Swanson J.M., and Potkin S.G. Lateralized attentional deficits in drug-free and medicated schizophrenic patients. Neuropsychologia 35 12 (1997) 1519-1525
37. Witte E.A., and Marrocco R.T. Alteration brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology 132 (1997) 315-323